Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is just one of its complex symptoms. Still, it has proved extremely difficult to treat. Fortunately for the Prader-Willi syndrome community, researchers continue to test potential therapies to find a comprehensive treatment or a way to curb the most severe symptoms.
There is still much to learn about how Prader-Willi syndrome works, but each new trial brings better answers, according to Jennifer L. Miller, MD, a professor in the division of pediatric endocrinology at the University of Florida. Miller has worked with patients with Prader-Willi syndrome and their families for 20 years.Learn more about ‘More Hopeful Outcomes’ on the Horizon for Prader-Willi Syndrome.